Market Exclusive

Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Underweight by JPMorgan Chase & Co.

ME Staff

Analyst Ratings For

Acorda Therapeutics Inc (NASDAQ:ACOR)

Today,

Acorda Therapeutics Inc (NASDAQ:ACOR) stock was downgraded by JPMorgan Chase & Co. from Neutral to Underweight.

There are 6 Hold Ratings, 3 Sell Ratings, 1 Buy Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on

Acorda Therapeutics Inc (NASDAQ:ACOR) is Hold with a consensus target price of $13.22 per share, a potential 525.16% upside.

Some recent analyst ratings include

  • 10/24/2019-
    Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Underweight by JPMorgan Chase & Co.
  • 8/14/2019-
    Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Neutral by HC Wainwright with a price target of $6.00
  • 3/19/2019-
    Acorda Therapeutics Inc (NASDAQ:ACOR) had its Hold rating reiterated by Oppenheimer
  • 1/7/2019-
    Acorda Therapeutics Inc (NASDAQ:ACOR) had its Buy rating reiterated by Cowen with a $30.00 price target
    • On 2/22/2019 Lauren M Sabella, Insider, sold 761 with an average share price of $13.18 per share and the total transaction amounting to $10,029.98.
    • On 1/30/2019 Scopia Capital Management Lp, Major Shareholder, sold 7,000 with an average share price of $16.01 per share and the total transaction amounting to $112,070.00.
    • On 1/25/2019 Scopia Capital Management Lp, Major Shareholder, sold 11,001 with an average share price of $16.02 per share and the total transaction amounting to $176,236.02.
    • On 1/23/2019 Scopia Capital Management Lp, Major Shareholder, sold 97,843 with an average share price of $16.01 per share and the total transaction amounting to $1,566,466.43.
    • On 1/17/2019 Scopia Capital Management Lp, Major Shareholder, sold 100,000 with an average share price of $16.86 per share and the total transaction amounting to $1,686,000.00.
    • On 1/15/2019 Scopia Capital Management Lp, Major Shareholder, sold 1,700 with an average share price of $16.60 per share and the total transaction amounting to $28,220.00.
    • On 1/10/2019 Scopia Capital Management Lp, Major Shareholder, sold 162,491 with an average share price of $17.18 per share and the total transaction amounting to $2,791,595.38.

    Recent Trading Activity for

    Acorda Therapeutics Inc (NASDAQ:ACOR)
    Shares of
    Acorda Therapeutics Inc closed the previous trading session at with 2.55 shares trading hands.